A Phase II study of Filanesib (ARRY-520) with patients with Advanced Multiple Myeloma

Clinical Trial Grant

Duke Scholars

Principal Investigator Cristina Gasparetto Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Array BioPharma Inc

Start Date

December 1, 2014

End Date

June 12, 2018

Administered By

Duke Cancer Institute

Awarded By

Array BioPharma Inc

Start Date

December 1, 2014

End Date

June 12, 2018